NCT07577336 Portable MRI for Pediatric Hypoxic Ischemic Brain Injury
| NCT ID | NCT07577336 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Mercy Hospital Kansas City |
| Condition | Acute Brain Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-07-06 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-07-06 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the sensitivity and specificity of low field portable MRI (pMRI) for detection of hypoxic ischemic brain injuries in pediatric patients compared to clinically obtained neuroimaging to define pediatric diagnostic limitations and to determine the diagnostic capabilities of this neuroimaging modality following optimization of image acquisition. The results of this study will help determine optimal clinical implementation opportunities in pediatric patients.
Eligibility Criteria
Inclusion Criteria * Patients hospitalized in the Pediatric Intensive Care Unit, Cardiac Intensive Care Unit, or the Neonatal Intensive Care Unit * Ages 0-17 years at study enrollment * Acute neurologic deficit suspected secondary to Hypoxic Ischemic Brain Injury (HIBI) or patients at high risk for HIBI Exclusion Criteria * Pregnancy * Active implants such as * Pacemaker * Implanted defibrillator * Implanted insulin pump * Deep brain stimulator * Vagus nerve stimulator * Cochlear implant * Programmable shunt * MRI incompatible surgical hardware (e.g., staples, screws, etc.) * Metal-containing tattoos or permanent make-up on head or neck * Suspected metal in eye, e.g., * Former or current welders, metal workers, or individuals with a metal injury * Metal shrapnel
Contact & Investigator
Jessica S Wallisch, MD
PRINCIPAL INVESTIGATOR
Children's Mercy Kansas City
Frequently Asked Questions
Who can join the NCT07577336 clinical trial?
This trial is open to participants of all sexes, up to 17 Years, studying Acute Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07577336 currently recruiting?
Yes, NCT07577336 is actively recruiting participants. Contact the research team at jwallisch@cmh.edu for enrollment information.
Where is the NCT07577336 trial being conducted?
This trial is being conducted at Kansas City, United States.
Who is sponsoring the NCT07577336 clinical trial?
NCT07577336 is sponsored by Children's Mercy Hospital Kansas City. The principal investigator is Jessica S Wallisch, MD at Children's Mercy Kansas City. The trial plans to enroll 200 participants.